全文获取类型
收费全文 | 6005篇 |
免费 | 506篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 66篇 |
妇产科学 | 26篇 |
基础医学 | 281篇 |
口腔科学 | 38篇 |
临床医学 | 887篇 |
内科学 | 2431篇 |
皮肤病学 | 18篇 |
神经病学 | 139篇 |
特种医学 | 438篇 |
外科学 | 422篇 |
综合类 | 518篇 |
预防医学 | 199篇 |
眼科学 | 20篇 |
药学 | 506篇 |
2篇 | |
中国医学 | 387篇 |
肿瘤学 | 233篇 |
出版年
2024年 | 19篇 |
2023年 | 217篇 |
2022年 | 384篇 |
2021年 | 487篇 |
2020年 | 397篇 |
2019年 | 480篇 |
2018年 | 435篇 |
2017年 | 212篇 |
2016年 | 160篇 |
2015年 | 192篇 |
2014年 | 438篇 |
2013年 | 354篇 |
2012年 | 282篇 |
2011年 | 301篇 |
2010年 | 197篇 |
2009年 | 189篇 |
2008年 | 225篇 |
2007年 | 252篇 |
2006年 | 152篇 |
2005年 | 143篇 |
2004年 | 95篇 |
2003年 | 88篇 |
2002年 | 68篇 |
2001年 | 72篇 |
2000年 | 52篇 |
1999年 | 60篇 |
1998年 | 60篇 |
1997年 | 54篇 |
1996年 | 27篇 |
1995年 | 42篇 |
1994年 | 45篇 |
1993年 | 29篇 |
1992年 | 43篇 |
1991年 | 37篇 |
1990年 | 32篇 |
1989年 | 28篇 |
1988年 | 31篇 |
1987年 | 34篇 |
1986年 | 27篇 |
1985年 | 32篇 |
1984年 | 31篇 |
1983年 | 24篇 |
1982年 | 23篇 |
1981年 | 18篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1973年 | 3篇 |
排序方式: 共有6613条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
《Pancreatology》2022,22(8):1175-1180
BackgroundHepatic steatosis has been described as a common finding in adults following total pancreatectomy with islet autotransplantation (TPIAT) but it is unknown if this occurs in children and adolescents.ObjectivesTo define the frequency of post-TPIAT hepatic steatosis in a sample of children and adolescents and to identify clinical predictors of incident steatosis post-TPIAT.MethodsIn this prospective study, consecutive participants at least 1-month post-TPIAT underwent a liver MRI with proton density fat fraction (PDFF) and blood draw at our pediatric academic medical center between April 2021 and January 2022. Comparison clinical pre-TPIAT liver MRI or ultrasound and insulin use and graft function data were extracted from the medical record. T-tests were used for the comparison of means across continuous variables between participants with and without post-TPIAT steatosis.ResultsA total of 20 participants (mean: 13 ± 4 years; 12 female) were evaluated. Mean liver PDFF at research MRI was 7.4 ± 6.2% (range: 2–25%). Seven participants (35%) had categorical hepatic steatosis (PDFF>5%) post-TPIAT, five of whom had pre-TPIAT steatosis, reflecting a 13% (2/15; 95% CI: 2–40%) incidence of post-TPIAT steatosis. Participant characteristics were not significantly different between subgroups with and without post-TPIAT steatosis. Mean PDFF at research MRI was not different between graft function subgroups (7.5% optimal/good vs. 7.3% marginal/failure; p = .96).ConclusionOur study shows a moderate prevalence but low incidence of hepatic steatosis in a small sample of children and adolescents post-TPIAT. This study raises questions about a causal relationship between TPIAT and hepatic steatosis. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):149-158.e4
BackgroundCoronary artery bypass grafting (CABG) improves survival in patients with heart failure and severely reduced left ventricular systolic function (LVEF). Limited data exist regarding adverse cardiovascular event rates after CABG in patients with heart failure with midrange ejection fraction (HFmrEF; LVEF > 40% and < 55%).MethodsWe analyzed data on isolated CABG patients from the Veterans Affairs national database (2010-2019). We stratified patients into control (normal LVEF and no heart failure), HFmrEF, and heart failure with reduced LVEF (HFrEF) groups. We compared all-cause mortality and heart failure hospitalization rates between groups with a Cox model and recurrent events analysis, respectively.ResultsIn 6533 veterans, HFmrEF and HFrEF was present in 1715 (26.3%) and 566 (8.6%) respectively; the control group had 4252 (65.1%) patients. HFrEF patients were more likely to have diabetes mellitus (59%), insulin therapy (36%), and previous myocardial infarction (31%). Anemia was more prevalent in patients with HFrEF (49%) as was a lower serum albumin (mean, 3.6 mg/dL). Compared with the control group, a higher risk of death was observed in the HFmrEF (hazard ratio [HR], 1.3 [1.2-1.5)] and HFrEF (HR, 1.5 [1.2-1.7]) groups. HFmrEF patients had the higher risk of myocardial infarction (subdistribution HR, 1.2 [1-1.6]; P = .04). Risk of heart failure hospitalization was higher in patients with HFmrEF (HR, 4.1 [3.5-4.7]) and patients with HFrEF (HR, 7.2 [6.2-8.5]).ConclusionsHeart failure with midrange ejection fraction negatively affects survival after CABG. These patients also experience higher rates myocardial infarction and heart failure hospitalization. 相似文献